zofran and birth defects

  • Date: Jun 01, 2015
  • Category: Family

Minnesota Mother Claims Zofran Caused Congenital Heart Defect In Two Pregnancies

On February 12, 2015, a parent from Alexandria, Minnesota filed the first claim in a litigation that has since grown to at least seven lawsuits. Families have brought claims for compensation against GlaxoSmithKline, the manufacturer of Zofran, an anti-nausea drug that these parents say causes major birth defects. Continue reading →

  • Date: May 08, 2015
  • Category: Family

A New Zofran Lawsuit Claims Birth Defects Caused Termination

On April 17, 2015, a woman from Massachusetts filed suit against pharmaceutical giant GlaxoSmithKline. She claims that Zofran, an anti-nausea drug frequently prescribed “off-label” to treat morning sickness, caused her unborn child to develop a severe abdominal birth defect. As a result, plaintiff was forced to terminate her pregnancy. Continue reading →

  • Date: Apr 28, 2015
  • Category: Family

Plaintiff In Texas Claims Zofran Caused “Numerous Birth Defects”

On April 17, 2015, a mother from Texarkana, Texas filed suit against GlaxoSmithKline, manufacturer of the anti-nausea drug Zofran. Plaintiff claims that Zofran, often prescribed “off-label” to treat morning sickness, caused her unborn child to develop multiple congenital defects. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →